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Article
The motogenic effect of EGF and TGF-a on
the migration of tumor cells from the oral
region: A role of epithelial-to-mesenchymal
transition in cancer and a route for
translation into the clinic
Mohammad Islam1, Shraddha Mane1, Erum Hyder1, Sarah Jones1 and Ian Ellis1
Abstract
Aim: Epithelial-to-mesenchymal transition (EMT) is recognized as a hallmark of cancer. The change in phenotype of epithelial cells
enables them to migrate and the cancer therefore, to become more aggressive. The presence of the epidermal growth factor
receptor (EGFR) has been implicated in the spread and aggressive nature of oral tumors. The aims of this present study were to
investigate the role of two different growth factors, both ligands of the receptor, and their influence on EMT and cellular motility.
Methods: A number of assays were used to investigate the response of the cells to the two growth factors (EGF and trans-
forming growth factor (TGF-a)). These techniques included the 2-D scratch assay, a 2-D-cell scatter assay, and immunocy-
tochemistry. Normal keratinocytes (HaCaT), oral adenoid squamous cell carcinoma (TYS), and human salivary gland tumor cells
were used in this study.
Results: The results of the scratch and scatter assays indicated that EGF and TGF-a exerted differential effects upon the cells.
EGF and TGF-a stimulated the migration of cancer cells in scratch assays. Scatter assays have revealed that both EGF and TGF-a
induce EMT. EGF- and TGF-a-induced scattering is EGFR dependent and localization of EMT markers (E-cadherin and vimentin)
might play an important role in scattering. These responses were also found to be dependent upon cell type, indicating that the
assay could also be used as a simple screen for active growth factor. The observed effects were also dose dependant (data not
shown).
Conclusion and implication for translation to clinic: We have previously reported that although EGF and TGF-a have
ultimately similar effects on motility, it would appear that different mechanisms are responsible. This data extends our knowledge
of the action of these growth factors to epithelial cell lines and will inform future testing of the effects of EGF and TGF-a inhibitors.
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Introduction
Head and neck cancer is the sixth most common cancer in the
world and squamous cell carcinoma (HNSCC) is the predomi-
nant form.1,2 While HNSCC patients have a 5-year survival
rate below 40%, patients with metastatic disease have an
extremely poor prognosis and a survival rate lower than
10%.3 The development of distant metastases, second primary
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tumors, and potentially inoperable recurrences with increased
resistance to radiation or chemotherapy are the main reasons
for mortality.4 Tumor cells must gain invasive ability to
develop metastases. The physiological process of epithelial-
to-mesenchymal transition (EMT) permits cells to change their
morphology, to lose polarity, and to become invasive.5 EMT is
a complex and reversible biological process, where an epithe-
lial tumor cell modifies its polar, adhesive phenotype to a
mesenchymal phenotype characterized by enhanced cell migra-
tion and invasive potential, cytoskeletal remodeling, and resis-
tance to apoptosis.6–8 In recent years, EMT has been
recognized as a key factor in cancer metastasis, allowing tumor
cells to leave the primary tumor microenvironment and to
migrate as circulating tumor cells to distant sites. Several reports
have established the link between EMT, progression, metastasis,
and chemoresistance in several types of cancer.9–11 Invasive
cells often exhibit a de-differentiated morphology, that is
complemented by a loss of epithelial markers such as
E-cadherin and cell–cell junctions and an increase in expression
of mesenchymal markers such as vimentin, N-cadherin, Twist,
and Snail.12–14 An association between loss of E-cadherin and
gain of vimentin with increased cancer cell migration and
enhanced metastatic risk in HNSCC patients was found
recently.15,16 Primary HNSCC with the EMT signatures (low
E-cadherin and high vimentin expression) has a 100%metastasis
rate, in comparison to a 44%metastasis rate for primary HNSCC
with partial or null EMT signatures.16
Epidermal growth factor receptor (EGFR) is a tyrosine
kinase receptor which is overexpressed in over 90% HNSCC
patients17–19 and associated with poor prognosis.20,21 EGF and
transforming growth factor-alpha (TGF-a), two natural ligands,
bind to the extracellular domain of EGFR and activate the recep-
tor and its downstream signal transduction pathways such as
PI3K/Akt, ERK-1/2, and Stat3 pathways, eventually causing
activation or modulation of several cellular processes.22 Activa-
tion of EGFR has been shown to decrease cell adhesion in sev-
eral solid malignancies including HNSCC leading to an increase
in cell migration and invasion.23,24 A study suggested that
Figure 1. Scratch assay of normal adult keratinocytes (HaCaT). After serum starvation, a wound was made in the monolayer and assays
incubated for 48 h in experimental conditions. Images were then captured every 24 h by an inverted microscope at 40 magnification. Images
were then edited using ImageJ software. Serum-free (SF) medium was used as a negative control. EGF: epidermal growth factor; TGF-a:
transforming growth factor alpha.
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HNSCC cells with high endogenous EGFR exhibited increased
cell motility and number of invasive cells, upon addition of
EGF.25 Studies so far have revealed that EGFR plays a crucial
role in the invasion and metastasis of HNSCC. However, the
mechanism of EGF- and TGF-a-induced HNSCC cell migra-
tion, in terms of EMT still need to be elucidated.
The aim of this study was to investigate the EMT phenotype
and expression of the relatedmarkers inEGF- andTGF-a-induced
HNSCC cells. It also aimed to elucidate the subcellular localiza-
tion of the EMT markers in EGF- and TGF-a-induced migrated
HNSCC cells. It was hypothesized that EGF and TGF-a moto-
genic activities (in terms of EMT) are mediated by the EGFR and
the subcellular localization of the markers is a better indicator of
EMT than the total expression of markers in HNSCC.
Materials and methods
Cell culture
The oral adenoid squamous cell carcinoma (OASCC) cell line
(TYS), derived from a minor salivary gland and the human
salivary gland (HSG) tumor, was a kind gift from Dr. Koji
Harada, University of Tokushima, Japan. Normal adult kerati-
nocytes (HaCaT) were a kind gift from Professor S.L. Schor
(late), Dundee Dental School, UK. All cells were cultured at
37C and 5% carbon dioxide in minimum essential medium
(MEM) supplemented with 10% (v/v) heat-inactivated fetal
calf serum and 200 mM glutamine.
Scratch assay
The scratch assay, a directional in vitro 2-D migration assay,
was performed as described earlier.26 A cell monolayer was
serum-starved overnight and then a wound was made in the
monolayer using a 100-ml pipette tip and the cells were then
incubated in different concentrations of EGF (#10-1001B) or
TGF-a (#10-1033C; both from Insight Biotechnology Inc.,
London, UK) for 48 h. Images were captured by an inverted
microscope (Olympus IX70, Osaka, Japan) at the starting point,
at 24 and at 48 h of the assay to monitor the cell migration
causing wound closure. Cells treated with serum-free (SF)
medium were used as a negative control.
Figure 2. Scratch assay of oral adenoid squamous cell carcinoma (TYS). A cell monolayerwas serum starved overnight and then a wound wasmade
using a pipette tip.Wounded cells were then incubated in experimental conditions for 48 h. Images were captured every 24 h at 100magnification
and edited. Serum-free (SF) medium was used as a negative control. EGF: epidermal growth factor; TGF-a: transforming growth factor-alpha.
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Scatter assay and immunofluorescent staining
Cell scattering is a dynamic process for investigating EMT in
which dispersion of compact colonies of epithelial cells is
induced by certain soluble factors such as growth factors.27
The assay was performed as described earlier.28,29 Cells were
seeded, with a density of 4 104 cells/ml, in 60 mm dishes and
grown until well-defined colonies (maximum 20 cells in a col-
ony) were visible. The cells were washed twice, serum starved
overnight, and incubated with the stated ligands diluted in SF
medium for 24 h. Scattering of the cells was observed by at
least two individuals before images were taken. Images were
captured using an Olympus inverted microscope at either 100
or 200 magnification.
After 24 h, the cells were fixed with cold methanol for 15
min and then washed with phosphate-buffered saline (PBS).
Cells were then treated with 0.2% (v/v) Triton X-100 in PBS
for 5 min, small areas of the dishes were ringed with Immuno-
pen (DAKO, Cambridgeshire, UK) and blocked with 5% (v/v)
normal goat serum (NGS; Vector Laboratories, Burlingame,
CA, USA) in PBS with 0.1% (v/v) Tween 20 (PBST) for 30
min. The cells were then washed with PBS and incubated with
anti-E-cadherin (1:200; #3195, Cell Signaling Technology,
Danvers, MA, USA), anti-vimentin (1:50; #3932, Cell Signal-
ing Technology), and anti-EGFR (1:500; # ab52894, Abcam,
Cambridge, UK) rabbit monoclonal primary antibodies diluted
in 5% (v/v) NGS in PBST and kept at 4C for overnight. They
were then washed twice with PBST, once with PBS and incu-
bated with anti-rabbit immunoglobulin G (HþL), F(ab0)2 Frag-
ment (Alexa Fluor1 488 Conjugate) is the name of secondary
antibody from cell signaling technology for 30 min at room
temperature. After washing twicewith PBST and oncewith PBS,
sections were cover slipped with aqueous mounting medium
(Sigma-Aldrich, St Louis,MO,USA). Sectionswere then viewed
with an Olympus IX70 inverted fluorescent micro-scope using
20 or 40 objective lenses. Images were collected using an
Olympus SC35 digital camera (Olympus). All devices were con-
trolled through the Metamorph v6.1 software (Molecular
Devices, Sunnyvale, CA, USA) and images were then processed
and analyzed by ImageJ software (NIH, Bathesda, MD, USA).
Figure 3. Scratch assay of human salivary gland (HSG) tumor cells. A cell monolayer was wounded after serum starvation and incubated for 48 h
in experimental conditions. Images were captured at 100 magnification. Serum-free (SF) medium was used as a negative control. EGF:
epidermal growth factor; TGF-a: transforming growth factor-alpha.
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Results
EGF and TGF-a stimulated the migration of cancer cells
Different concentrations (500 pg/ml, 1 ng/ml, 10 ng/ml, and 50
ng/ml) of EGF and TGF-a were used in the scratch assay.
Maximum stimulation of migration was observed at 50 ng/ml
of each growth factor. A 48-h incubation of the test cells in the
scratch assay revealed that 50 ng/ml of EGF did not stimulate
normal keratinocytes (HaCaT) to migrate (Figure 1), whereas
OASCC cells (TYS) were stimulated to migrate (Figure 2) in
response to the same concentration of EGF. In contrast, oral
HSG tumor cells showed partial gap closure after 48 h of EGF
stimulation (Figure 3). However, TGF-a stimulated the migra-
tion of normal keratinocytes after 48 h of incubation (Figure 1)
and oral adenocarcinoma after 24 h (the cells started to die after
48 h; Figure 2). EGF- and TGF-a-induced migration of oral
salivary gland tumor cells was not significantly higher than that
of the negative control (Figure 3). Single-cell migration was
observed in TGF-a-induced normal keratinocytes, whereas
other cells showed collective cell migration upon EGF and
TGF-a stimulation (Figure 1). SF MEM was used as negative
control and EGF and TGF-a as a stimulant in this study.
Scatter assays revealed that both EGF and TGF-a induce
EMT
Cellswere plated at both high (4 105 cells/ml) and low (4 104
cells/ml) density to analyze the effect of EGF and TGF-a on cell
scattering.No scattering of cells was observedwith cells plated at
high density upon addition of EGF or TGF-a (results not shown).
However, cells plated at low density formed small colonies and
stimulation of cells with EGF and TGF-a for 24 h revealed a
colony scatter effect. A range of concentrations (500 pg/ml, 1
ng/ml, 10 ng/ml, and 50 ng/ml) of EGF and TGF-a were used
in this assay and effective scattering was observed at or over 10
ng/ml.Normal keratinocytes (Figure 4) andHSG tumor cell colo-
nies (Figure 5) were scattered into single cells and a morpholo-
gical change of epithelial cells to mesenchymal type was
observed upon addition of EGF andTGF-a. This type ofmorpho-
logical change is called EMTorEMT. Furthermore,OASCCalso
showed scattering into single cells upon addition of EGF and
TGF-a, but EGF-induced OASCC displayed a unique change in
morphology which resembled a cytoskeletal rearrangement
(Figure 6). Filopodia and lamellipodia were observed in EGF-
induced scattered OASCC cells; these are the classic features of
actin remodeling, another mechanism involved in cell migration.
Figure 4. Scatter and immunofluorescence assays of HaCaT cells. Small colonies of cells were serum starved and incubated in experimental
conditions for 24 h. Cells were then fixed and stained with E-cadherin, vimentin, and EGFR antibodies. Images were captured by inverted
fluorescence microscope with a CCD camera and edited using ImageJ software. Normal light images were captured at 40 magnification and
fluorescent images were captured at 200 magnifications. Serum-free (SF) medium was used as a negative control. EGFR: epidermal growth
factor receptor; TGF-a: transforming growth factor-alpha.
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EGF- and TGF-a-induced scattering is EGFR dependent
and localization of EMT markers might play an
important role in scattering
Scattering is the visible phenotype at the end of an extensive
cellular signaling cascade.28 Hence, it was investigated
whether the results of the scattering assays are reflected by
EGFR-dependent signaling. After 24 h of scatter assay obser-
vation, immunofluorescent assay of the cells, after fixing, was
employed to investigate the expression and localization of
vimentin (a mesenchymal marker), E-cadherin (an epithelial
marker), and EGFR in the cells. SF medium-treated normal
keratinocytes expressed E-cadherin, vimentin, and EGFR.
Vimentin was found to be highly expressed in a diffuse pattern,
while weak cytoplasmic E-cadherin and strong expression of
EGFR in the cell membrane were observed in SF medium-
treated normal keratinocytes (Figure 4). EGF-treated scattered
normal keratinocytes also expressed vimentin, E-cadherin, and
EGFR (Figure 4). A strong diffuse expression of E-cadherin
and EGFR was observed. Contrary to predictions, vimentin was
observed on the nuclear membrane of the EGF-treated scat-
tered normal keratinocytes (Figure 4). Moreover, TGF-a-
treated scattered normal keratinocytes revealed a strong diffuse
expression of vimentin and EGFR but a very weak expression
of E-cadherin (Figure 4). SF medium-treated OASCC cells
displayed upregulated E-cadherin expression in contrast to
downregulated vimentin (Figure 5). An elevated and diffuse
expression of EGFR was also observed in SF media-treated
OASCC cells. EGF-treated scattered OASCC cells displayed
filopodia (red arrow) and lamellipodia (white arrow), which are
the characteristic features of cytoskeletal rearrangement
(Figure 5). A cytoplasmic upregulation of E-cadherin, very
weak expression of vimentin, and an elevated diffuse expres-
sion of EGFR were exhibited in EGF-treated scattered OASCC
cells (Figure 5). However, TGF-a-treated scattered OASCC
cells displayed an EMT phenotype, downregulated
E-cadherin and nuclear vimentin, and strong cytoplasmic
EGFR expression (Figure 5). HSG tumor cells, treated with
SF medium, expressed elevated vimentin, EGFR, and E-
cadherin (Figure 6). The expression of vimentin was diffuse,
E-cadherin was downregulated, and EGFR was in the cell
membrane (Figure 6). EGF-treated HSG tumor cells were scat-
tered after 24 h and showed EMT phenotype. Downregulated
E-cadherin and upregulated vimentin expression confirms
EMT in EGF-treated salivary gland tumor cells (Figure 6).
Vimentin expression was observed in the nuclear membrane
Figure 5. Scattering of oral adenoid squamous cell carcinoma (TYS) with immunofluorescent staining. Scattering of cells were observed within
24 h of adding growth factors. Cells were then fixed and stained with E-cadherin, vimentin, EGFR primary antibodies, and fluorescent-tagged
secondary antibodies. Images were captured at 100 (normal light) and 200 (fluorescent) magnification and edited using ImageJ software.
White arrow: lamellipodia; red arrow: filopodia. Serum-free (SF) medium was used as a negative control. EGFR: epidermal growth factor
receptor; TGF-a: transforming growth factor-alpha.
6 Translational Research in Oral Oncology
and EGFR expression was in the cytoplasm and/or in the cell
membrane. TGF-a-treated scattered salivary gland tumor cells
also showed an EMT phenotype (Figure 6). The expression
pattern of vimentin, E-cadherin, and EGFR was similar to that
of EGF-treated tumor cells (Figure 6).
Discussion
In this study, wound healing (scratch) and scatter assays were
included to investigate the two different modes of cell migra-
tion. The wound healing (or scratch) assay is a popular 2-D in
vitro assay to visualize collective cell migration that allows
polarization, force generation, and mechanism of cell–cell
adhesion to be studied during the movement of confluent
monolayers.30–32 Normal keratinocytes (HaCaT) were stimu-
lated to migrate upon addition of TGF-a in the wound healing
assay, whereas EGF was not able to stimulate normal kerati-
nocytes to migrate. In this assay, TGF-a-induced normal ker-
atinocytes migrated as single cells, the opposite to collective
migration. A recent wound healing study suggested that kera-
tinocytes (HaCaT) migrate as single cells via EMT during the
healing process33. Moreover, OASCC cells were stimulated
and HSG tumor cells were partially stimulated to migrate as
a collective sheet by both EGF and TGF-a. In comparison, both
normal keratinocytes and HSG tumor cells showed a distinctive
EMT phenotype during single-cell migration, upon addition of
EGF and TGF-a in the scatter assay. OASCC cells also exhib-
ited an EMT phenotype upon addition of TGF-a, whereas EGF-
stimulated scattered cells showed filopodia and lamellipodia in
contrast to the EMT phenotype. EGFR was highly expressed in
both SF medium-treated nonscattered and EGF- and TGF-a-
induced scattered cells. But EGFR was localized in the mem-
brane of nonscattered cells, whereas it was found either in the
cytoplasm and/or in the nucleus of scattered cells. The locali-
zation pattern of EGFR in migrated cells fits with the concept
of intracellular membrane trafficking during the cell signaling
process. At the cellular level, receptor tyrosine kinases such as
EGFR need to be localized in a specific location to function as
signal receiving and transmitting devices.34 EGFR must be
exposed at the surface of the plasma membrane to receive
signals, that is, to bind extracellular ligands, such as EGF and
TGF-a. To transmit signals after ligand binding by EGFR,
suitable signaling machinery has to be available within the
intracellular compartments of the cytoplasm, in association
with membrane bound organelles and in the nucleus.35,36
Increasing evidence suggests that intracellular membrane
trafficking, such as endocytic internalization (entering of the
components of plasma membrane, cell surface receptors, and
Figure 6. Immunofluorescent assay of scattered and fixed salivary gland tumor cells (HSG). Small colonies of cells were scattered within 24 h of
adding growth factors. Scattered cells were then fixed and stained with E-cadherin, vimentin, and EGFR antibodies. Images were captured at 40
(normal light) and 200 (fluorescent) magnification. Images were then edited using ImageJ software. Serum-free (SF) medium was used as a
negative control. EGFR: epidermal growth factor receptor; TGF-a: transforming growth factor-alpha.
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various soluble molecules into the cell by endocytosis36),
degradation, and recycling, can profoundly affect the signaling
properties of EGFR.34,37,38 To explain the fate of EGF- and
TGF-a-induced EGFR activation in scattered cells requires
further investigation. This study revealed that intracellular
localization as well as expression of EGFR has an important
effect on cell migration. To confirm the EMT phenotype of
migrated cells, immunofluorescent staining of two widely used
EMT markers, E-cadherin and vimentin, was carried out. EGF-
treated normal keratinocytes and HSG tumor cells showed peri-
nuclear vimentin expression in scattered cells, in comparison to
cytoplasmic vimentin expression in SF medium-treated non-
scattered cells. Moreover, TGF-a-treated scattered cells exhib-
ited a varied pattern of vimentin localization such as
cytoplasmic/perinuclear (normal keratinocytes), perinuclear
(salivary gland tumor), and weak nuclear (OASCC). Recent
studies have revealed that vimentin interacts directly with the
microtubules via microtubule-associated protein, kinesin, or
indirectly through intermediate filament-associated proteins,
such as plectin at the perinuclear region, and mediates micro-
tubule polarization to support cell migration.39–41 High expres-
sion of cytoplasmic E-cadherin and very weak vimentin
expression in EGF-treated OASCC scattered cells also demon-
strated another mechanism of cell migration via actin reorga-
nization, that is, lamellipodia and filopodia. Subcellular
localization of markers has already been shown to be a
better indicator of EMT than only the expression of the
markers.16,42–44 This study therefore revealed that EGF and
TGF-a stimulate the migration of both normal and cancer cells,
which supports the idea that these ligands could induce cell
migration during both wound healing and cancer metastasis. The
mode of cell migration and associated signaling cascade, how-
ever, largely depend on the cell types, assay format, incubation
time, and available concentrations of the ligands. Moreover, it
may not be prudent to interpret the data in terms of squamous
cell carcinoma (as the cell lines used were OASCC cell line
(TYS), derived from a minor salivary gland, HSG tumor, and
normal adult keratinocytes (HaCaT)). A direct comparison of
results from HaCaT with a squamous cell carcinoma cell line
would be required to extrapolate the data directly to oral cancer.
Investigating the downstream signaling pathways of EGFR
responsible for EMT in oral squamous cell carcinoma would be
essential in translating the research into clinical practice in future.
Conclusion
This study has demonstrated the role of EGF and TGF-a on the
cell migration of HNSCC through EMT. However, there are
several omissions in the published data regarding EMT which
need to be addressed to gain a more comprehensive understand-
ing of the EMT process in HNSCC. HNSCC covers several
subsites and each subsite and stage may have unique features
which could regulate EMT through overlapping and diverse
mechanisms. A better understanding of the role of EMT in
HNSCC metastases and associated signaling pathways could
lead to the design and therapeutic use of EMT-targeting drugs
and may ultimately help to decrease HNSCC-associated mor-
bidity and mortality.
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Translational value
Results presented here indicate that the motogenic activ-
ities of epidermal growth factor receptor (EGF) and
transforming growth factor-alpha are mediated by the
EGFR via the induction of epithelial-to-mesenchymal
transition (EMT). Therefore, inhibition of EMT or its
reversal appears to be an attractive therapeutic target
in wound healing and to diminish cancer cell invasion
and therefore the potential formation of metastases by
human cancers including HNSCC.
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